Publication | Open Access
397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer
26
Citations
0
References
2021
Year
MedicineR-immune Interim AnalysisImmunologyPathologyImmune Checkpoint InhibitorPhase Ib/ii StudyCancer TreatmentLocalized Rectal CancerOncologyRadiation OncologyTumor Microenvironment
No additional data available for this publication yet. Check back later!